Paul Gesta

Mutational spectrum in a worldwide study of 29,700 families with<i>BRCA1</i>or<i>BRCA2</i>mutations

Timothy R. Rebbeck, Tara M. Friebel, Eitan Friedman et al. · Human Mutation · 2018 · 314 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Germline BAP1 Mutations Predispose to Renal Cell Carcinomas

Tatiana Popova, Lucie Hebert, Virginie Jacquemin et al. · The American Journal of Human Genetics · 2013 · 276 citations · Full text

Medicine, Molecular Biology, Oncology +14

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

Érick Gamelin, E Danquechin‐Dorval, Y. Dumesnil et al. · Cancer · 1996 · 217 citations · Full text

Medicine, Oncology, Pharmacology +17

Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients.

Érick Gamelin, M. Boisdron‐Celle, R. Delva et al. · Journal of Clinical Oncology · 1998 · 159 citations

Medicine, Oncology, Pharmacology +17

Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

Daniel R. Barnes, Matti A. Rookus, Lesley McGuffog et al. · Genetics in Medicine · 2020 · 145 citations · Full text

Life Sciences, Genetics, Oncology +17